Skip to main content

Table 1 Case Reports/Series of Ipilimumab-Associated Neurological irAEs

From: Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Case reports/series Neurological manifestations Presence of additional irAEs
Wilgenhof S, et al. (2011) [23] Guillain-Barré Syndrome None reported
Bompaire F, et al. (2012) [18] Meningo-radiculo-neuritis None reported
Bot I, et al. (2013) [21]
(n = 3)
Hypophysitis
Meningitis
Guillain-Barré syndrome
 
Liao B. et al. (2014) [21]
(n = 3)
CIDP
Transverse myelitis
Myasthenia gravis-type syndrome
None reported
Johnson DB, et al. (2015) [24] Myasthenia gravis Thyroiditis
Dermatitis
Thaipisuttikul I, et al.(2015) [35] Peripheral neuropathy None reported
Abdallah AO, et al. (2016) [31] Necrotic myelopathy None reported
Chen JH, et al. (2017) [27] Myasthenia gravis Myositis
Polyneuropathy
Hepatitis
Derle E, et al. (2018) [25] Myasthenia gravis None reported
Montes V, et al. (2018) [26] Myasthenia gravis None reported
Naito T, et al. (2018) [22] Acute cerebellitis None reported
Ruff MW, et al. (2018) [28]
(n = 2)
Bilateral phrenic nerve paralysis
Bell’s palsy
Pan-hypopituitarism